Numeta G16%E emulsion for infusion
- Name:
Numeta G16%E emulsion for infusion
- Company:
Baxter Holding B.V.
- Active Ingredients:
Alanine, Arginine, Aspartic acid, Calcium Chloride Dihydrate, Cysteine, Glucose Monohydrate, Glutamic acid, Glycine, Histidine, Isoleucine, Leucine, Lysine, Magnesium acetate tetrahydrate, Methionine, Ornithine, Phenylalanine, Potassium acetate, Proline, Refined olive oil, Refined soybean oil, Serine, Sodium Chloride, Sodium glycerophosphate, hydrated, Taurine, Threonine, Tryptophan, Tyrosine, Valine
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Click on this link to Download PDF directly
Baxter Holding B.V.
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 2 March 2021 SPC
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 3 December 2020 SPC
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 6.1 - List of excipients
- Change to section 6.2 - Incompatibilities
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 4 April 2019 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 9 February 2017 PIL
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Section 9 Date of last revision entered
Section 10 Date amended to January 2017
Updated on 9 February 2017 SPC
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 9 Date of last revision entered
Section 10 Date amended to January 2017
Updated on 9 February 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 4 October 2016 PIL
Reasons for updating
- New SPC for medicines.ie
Free text change information supplied by the pharmaceutical company
Updated on 4 October 2016 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may not be renewed (A)